article thumbnail

FDA and Digital Health Regulation

Health Blawg

These publications come as part of the FDA’s effort to improve its approach to digital health, to continue to work on drawing the line between digital health tools that are properly regulated as “devices” by the FDA and those that are not. signals from in vitro diagnostic devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

These publications come as part of the FDA’s effort to improve its approach to digital health, to continue to work on drawing the line between digital health tools that are properly regulated as “devices” by the FDA and those that are not. signals from in vitro diagnostic devices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

These publications come as part of the FDA’s effort to improve its approach to digital health, to continue to work on drawing the line between digital health tools that are properly regulated as “devices” by the FDA and those that are not. signals from in vitro diagnostic devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

These publications come as part of the FDA’s effort to improve its approach to digital health, to continue to work on drawing the line between digital health tools that are properly regulated as “devices” by the FDA and those that are not. signals from in vitro diagnostic devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

These publications come as part of the FDA’s effort to improve its approach to digital health, to continue to work on drawing the line between digital health tools that are properly regulated as “devices” by the FDA and those that are not. signals from in vitro diagnostic devices.

article thumbnail

The The Five Biggest Areas of Opportunity for Digital Health

The Digital Health Corner

I agree that traditional trials are neither practical nor necessary for most tools. Thus, the opportunity for trials utilizing digital registries, mobile clinical trial platforms, quality communications and analytics tools is significant. This should not however translate to “take my word for it” is all you need. Bring it!

article thumbnail

Branding, Cheerleading, and even some Progress

Chilmark Research

For better or for worse, the event continues to be a one-of-a-kind affair; Matthew and Indu have a built a big tent brand that welcomes any and all variants of health tech, from social networking tools for athletes to economic development boards from Finland and Japan. Workflow or Traffic Jam?

EHR 60